221 related articles for article (PubMed ID: 34702064)
1. Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study.
Wang X; Minhas JS; Moullaali TJ; Di Tanna GL; Lindley RI; Chen X; Arima H; Chen G; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Thang NH; Wang JG; Woodward M; Chalmers J; Song L; Anderson CS; Robinson TG;
Stroke; 2022 Mar; 53(3):779-787. PubMed ID: 34702064
[TBL] [Abstract][Full Text] [Related]
2. Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial.
Chen C; Wang X; Chen X; Ouyang M; Sun L; Arima H; Robinson T; Lindley RI; Chalmers J; Li G; Song L; Anderson CS;
Cerebrovasc Dis; 2021; 50(5):560-566. PubMed ID: 34153968
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
[TBL] [Abstract][Full Text] [Related]
4. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
[TBL] [Abstract][Full Text] [Related]
5. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
6. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target.
Zhou Z; Xia C; Mair G; Delcourt C; Yoshimura S; Liu X; Chen Z; Malavera A; Carcel C; Chen X; Wang X; Al-Shahi Salman R; Robinson TG; Lindley RI; Chalmers J; Wardlaw JM; Parsons MW; Demchuk AM; Anderson CS
Int J Stroke; 2022 Jun; 17(5):566-575. PubMed ID: 34096413
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial.
Minhas JS; Wang X; Lindley RI; Delcourt C; Song L; Woodward M; Lee TH; Broderick JP; Pontes-Neto OM; Kim JS; Ricci S; Lavados PM; Bath PM; Durham AC; Wang JG; Sharma VK; Demchuk AM; Martins SO; Chalmers J; Anderson CS; Robinson TG;
J Hypertens; 2021 Feb; 39(2):280-285. PubMed ID: 33031175
[TBL] [Abstract][Full Text] [Related]
8. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
[TBL] [Abstract][Full Text] [Related]
9. Blood Pressure in the First 6 Hours Following Endovascular Treatment for Ischemic Stroke Is Associated With Outcome.
Samuels N; van de Graaf RA; van den Berg CAL; Uniken Venema SM; Bala K; van Doormaal PJ; van der Steen W; Witvoet E; Boiten J; den Hertog H; Schonewille WJ; Hofmeijer J; Schreuder F; Schreuder TAHCML; van der Worp HB; Roos YBWEM; Majoie CBLM; Burke JF; van Es ACGM; van der Lugt A; Roozenbeek B; Lingsma HF; Dippel DWJ;
Stroke; 2021 Nov; 52(11):3514-3522. PubMed ID: 34538090
[TBL] [Abstract][Full Text] [Related]
10. Intensive blood pressure lowering and renal function in ischemic stroke patients: secondary analysis of ENCHANTED trial.
Chen C; Ren X; Zhao Y; Ouyang M; Li Mbiostat Q; Wang X; Li Y; You S; Wang Y; Robinson TG; Lindley R; Arima H; Chalmers J; Li G; Chen X; Anderson CS; Song L
Cerebrovasc Dis; 2024 Jan; ():. PubMed ID: 38228119
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.
Nagel S; Wang X; Carcel C; Robinson T; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2018 Jun; 49(6):1407-1411. PubMed ID: 29777016
[TBL] [Abstract][Full Text] [Related]
13. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
[TBL] [Abstract][Full Text] [Related]
14. Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment.
van den Berg SA; Uniken Venema SM; Mulder MJHL; Treurniet KM; Samuels N; Lingsma HF; Goldhoorn RB; Jansen IGH; Coutinho JM; Roozenbeek B; Dippel DWJ; Roos YBWEM; van der Worp HB; Nederkoorn PJ;
Stroke; 2020 Nov; 51(11):3205-3214. PubMed ID: 33040702
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
Koga M; Yamamoto H; Inoue M; Asakura K; Aoki J; Hamasaki T; Kanzawa T; Kondo R; Ohtaki M; Itabashi R; Kamiyama K; Iwama T; Nakase T; Yakushiji Y; Igarashi S; Nagakane Y; Takizawa S; Okada Y; Doijiri R; Tsujino A; Ito Y; Ohnishi H; Inoue T; Takagi Y; Hasegawa Y; Shiokawa Y; Sakai N; Osaki M; Uesaka Y; Yoshimura S; Urabe T; Ueda T; Ihara M; Kitazono T; Sasaki M; Oita A; Yoshimura S; Fukuda-Doi M; Miwa K; Kimura K; Minematsu K; Toyoda K;
Stroke; 2020 May; 51(5):1530-1538. PubMed ID: 32248771
[TBL] [Abstract][Full Text] [Related]
16. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.
Wang X; Robinson TG; Lee TH; Li Q; Arima H; Bath PM; Billot L; Broderick J; Demchuk AM; Donnan G; Kim JS; Lavados P; Lindley RI; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Thang NH; Wang JG; Woodward M; Anderson CS; Chalmers J;
JAMA Neurol; 2017 Nov; 74(11):1328-1335. PubMed ID: 28973174
[TBL] [Abstract][Full Text] [Related]
18. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial.
Li S; Wang X; Jin A; Liu G; Gu H; Li H; Campbell BCV; Fisher M; Yang Y; Wei Y; Wang J; Wang Y; Zhao X; Liu L; Li Z; Meng X; Wang Y
Stroke; 2024 Feb; 55(2):366-375. PubMed ID: 38152962
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
Hacke W; Kaste M; Bluhmki E; Brozman M; Dávalos A; Guidetti D; Larrue V; Lees KR; Medeghri Z; Machnig T; Schneider D; von Kummer R; Wahlgren N; Toni D;
N Engl J Med; 2008 Sep; 359(13):1317-29. PubMed ID: 18815396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
